Healthcare
ID: MRFR/HC/55274-HCR
200 Pages
Rahul Gotadki
10/2025
China Overactive Bladder Treatment Market Research Report By Treatment Type (Anticholinergics, Beta-3 Adrenergic Agonists, Neuromodulation, Botulinum Toxin Injections, Behavioral Therapies), By Route of Administration (Oral, Intravesical, Transdermal, Injectable), By Patient Type (Adult, Geriatric, Pediatric) and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Forecast to 2035
ID: MRFR/HC/55270-HCR
200 Pages
Rahul Gotadki
10/2025
GCC Overactive Bladder Treatment Market Research Report By Treatment Type (Anticholinergics, Beta-3 Adrenergic Agonists, Neuromodulation, Botulinum Toxin Injections, Behavioral Therapies), By Route of Administration (Oral, Intravesical, Transdermal, Injectable), By Patient Type (Adult, Geriatric, Pediatric) and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Forecast to 2035
ID: MRFR/HC/55264-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/55263-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/55262-HCR
200 Pages
Rahul Gotadki
10/2025
ID: MRFR/HC/55261-HCR
200 Pages
Rahul Gotadki
10/2025
ID: MRFR/HC/55260-HCR
200 Pages
Rahul Gotadki
10/2025
ID: MRFR/HC/55259-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/55258-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/55257-HCR
200 Pages
Rahul Gotadki
10/2025